In humans, evidence exists for the ability of insulin to promote inflammation during acute, experimentally-induced hyperinsulinemia, independent of obesity, increasing inflammatory cytokine concentrations in subcutaneous adipose tissue interstitial fluid as well as circulating IL-6 concentrations [49,50]. The gene discussed is INS; the disease is obesity disorder.